MAPK8 and Alzheimer disease: The role of JNK in AD post-synaptic dysfunction was previously investigated in the CRND8 AD mouse model, where it was shown to regulate synaptic glutamate receptor trafficking by controlling phosphorylation of PSD95, eventually leading to neurotransmission impairments and spine loss [3,10,13].